Articles tagged with "Virology"

Sort by

Survival of coronavirus in different cities, on different surfaces

June 11, 2020
One of the many questions researchers have about COVID-19 is how long the coronavirus causing the disease remains alive after someone infected with it coughs or sneezes. Once the droplets...

Widespread facemask use could shrink the ‘R’ number and prevent a second COVID-19 wave

June 10, 2020
Population-wide use of facemasks keeps the coronavirus 'reproduction number' under 1.0, and prevents further waves of the virus when combined with lockdowns, a modelling study from the universities of Cambridge...

What’s your poison?

May 10, 2020
Why are so many drugs derived from natural sources on the market to treat human disease? Venom-master Steve Trim explains how evolution can give us a Pharmaceutical short-cut.

A counterintuitive approach to treating Covid-19

May 3, 2020
A new USC study suggests that temporarily suppressing the body's immune system during the early stages of COVID-19 could help a patient avoid severe symptoms. Research, published online in the...

Going (anti)viral

April 27, 2020
Dermot Martin catches us up with the rapid reaction of the biopharma community to meet the Covid-19 antiviral quest

A very positive destruction

December 2, 2019
Totally eradicating disease is a very rare thing indeed and requires, among other things, global cooperation and technical excellence. Here we learn that keeping one of the most catastrophic diseases...

Procarta awarded £7.4M for microbial treatment

September 23, 2019
Biotechnology company Procarta Biosystems will receive up to £7.4 million to develop a new class of antibiotics in the fight against antimicrobial resistance.

Going viral

August 28, 2019
Foodborne viruses present a major challenge to the safety of a range of foods including ready–to–eat products, fresh produce and pork products. While viruses cannot grow in or on foods,...

Ebola patients cured with mAb drugs

August 13, 2019
Two monoclonal antibody drugs will be used to treat Ebola patients in the Democratic Republic of Congo (DRC) following a successful nine-month trial.

Pin It on Pinterest